June 19, 2020 / 12:27 PM / 15 days ago

BRIEF-Acasti Pharma Receives FDA Response To Trilogy 1 Briefing Package

June 19 (Reuters) - Acasti Pharma Inc:

* ACASTI PHARMA RECEIVES FDA RESPONSE TO TRILOGY 1 BRIEFING PACKAGE

* ACASTI PHARMA INC - FDA HAS PROVIDED ACASTI WITH A WRITTEN RESPONSE TO ITS TYPE C MEETING REQUEST AND BRIEFING PACKAGE

* ACASTI PHARMA - FDA CONFIRMED THAT IT WILL REQUIRE PIVOTAL EFFICACY ANALYSES FOR TRILOGY 2 TO BE PERFORMED ON FULL INTENT TO TREAT POPULATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below